PORTFOLIO COMPANIES


Blue Belt Technologies





prior investment

HealthpointCapital is a values-driven, research-based private equity firm
exclusively focused on the musculoskeletal sector — specifically orthopedics and dental. HealthpointCapital manages in excess of $800 million of institutional capital.

Orthopedic & Dental Industry Research Most Recent Blog Articles

Musculoskeletal News Roundup 18-Sep-14 BY ANDREW VAHRADIAN, SEPTEMBER 18, 2014

DePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA HP Partial Knee on the Navio Surgical System...Nimbic Systems, Spine Pain Management, Tissue Regeneration Systems receive funding...Baxano exploring strategic alternatives...ChoiceSpine, EOS imaging receive 510(k) clearance...Amedica, Aurora Spine, Integra, K2M, Medtronic, NovaBone, Smith & Nephew, Spineology launch products...OMNIlife announces milestone...Orthocell receives patent...Ortho Kinematics enters agreement with Medtronic more

Baxano Surgical Announces it is Exploring Potential Strategic Alternatives BY ANDREW VAHRADIAN, SEPTEMBER 18, 2014

Baxano Surgical has engaged Houlihan Lokey as its financial advisor to advise it on potential strategic alternatives for business. Management believes the company is an attractive asset as it has made encouraging progress on its major milestones in 2014, including... more

DePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA HP Partial Knee on the Navio Surgical System BY EDITOR, SEPTEMBER 17, 2014

DePuy Synthes, the world's largest provider of orthopaedic and neurological solutions, announced today a worldwide commercial agreement with Blue Belt Technologies, a global medical technology company specializing in enabling technologies for orthopaedic surgery. The agreement will enable orthopaedic surgeons to... more

Danaher to Acquire Nobel Biocare for $2.2B BY ANDREW VAHRADIAN, SEPTEMBER 15, 2014

Danaher Corporation entered into an agreement to acquire the Z├╝rich, Switzerland-based Nobel Biocare, the second largest dental implant developer, in an all cash transaction valued at an enterprise value of $2.2 billion, or 3.0x LTM revenues, or 16.0x LTM EBITDA.... more

Complete Archive »


Search the HealthpointCapital Site